The epidemiology and pathogenesis of Burkitt lymphoma
Investigation of prognostic markers in endemic Burkitt lymphoma
Childhood Burkitt lymphoma in North Africa: a study of the French-African Pediatric Oncology Group (G.F.A.O.P.)
Burkitt's lymphoma at the Unidad Nacional De Oncologia Pediatrica (UNOP) Guatemala
Mechanisms of B cell lymphomagenesis and their therapeutic implications
Epigenetic alterations in diffuse large B-cell lymphoma
The BCL6 network and its role in lymphomagenesis
Reduced burden of chemotherapy in children, adolescents and young adults (CAYA) with French-American -British Group B mature B Cell Lymphoma (FAB B-MBCL)
Outcome of relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in the Rituximab Era: a study of the Société Française des Cancers de l'Enfant
Excellent outcomes in children and adolescents with central nervous system-positive (CNS+) Burkitt lymphoma/leukemia (BL) or other mature B-NHL using intrathecal and systemic chemotherapy without CNS irradiation: results from FAB/LMB96 and ANHL01P1 studies
Micro RNAs and therapy resistant phenotypes in Burkitt lymphoma cells
Pathological and genetic factors of adolescent primary mediastinal B-cell lymphomas and gray zone lymphomas
Promising new targeted therapy in young adult Non-Hodgkin lymphoma
A revised international pediatric Non-Hodgkin lymphoma (NHL) staging system (IPNHLSS)
International pediatric Non-Hodgkin lymphoma response criteria
Biopathology of peripheral T-cell and NK Non-Hodgkin lymphoma in children adolescents and young adults
Treatment of extranodal NK and T-cell lymphoma
Autologous versus allogeneic hematopoietic stem cell transplantation for patients with T-cell and NK Non-Hodgkin lymphoma
Non-anaplastic peripheral T-cell lymphoma in children and adolescents - International review
HIV-Associated Non-Hodgkin lymphoma and malignancies in children: the Malawi experience
New advances on CAR T-cell therapy in B-cell NHL
Latent-membrane protein cytotoxic T lymphocytes (CTL) for Non-Hodgkin lymphoma and PTLD lymphoma
Myeloablative conditioning autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning allogeneic SCT in children, adolescents, and young adults with poor-risk refractory/relapsed mature B-cell non-Hodgkin lymphoma
Kinetics of humoral response to ALK in children with anaplastic large cell lymphoma: the AIEOP and BFM experience
TH2 CD4+-polarizing cytokines are associated with aberrant B cell proliferation in African Burkitt lymphoma
Diagnosis and treatment of post-transplant lymphoproliferative disease: challenging cases
Diagnosis and treatment of mature B-cell lymphoma in children: challenging cases
International pediatric Non-Hodgkin lymphoma response criteria
New pathologic entities in NHL in the upcoming revised WHO classification
Recurrent activating MAPK pathway gene mutations in Langerhans cell histiocytosis
Treatment and prognosis of childhood and adolescent anaplastic large cell lymphoma
Minimal disseminated disease and minimal residual disease in childhood and adolescent anaplastic large cell lymphoma
Targeted therapeutic approaches in anaplastic large cell lymphoma
NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development
ALK+ ALCLs are deficient in the T-cell costimulatory protein CD48: role in immune evasion
Clinical features and treatment outcomes of children with anaplastic large cell lymphoma: a report from the Taiwan Pediatric Oncology Group
Minimal residual disease in monitoring childhood and adolescent T-lymphoblastic and Burkitt lymphoma
Targeting the PI3K/AKT pathway in B-cell Non-Hodgkin lymphoma
Immune response to ALK in ALK-positive anaplastic large cell lymphoma
Central nervous system invasion by T-cell lymphoblastic lymphoma
MK-2206, an Akt inhibitor, decreases proliferation, induces cell cycle arrest and increases responsiveness to chemotherapy in therapy-sensitive and -resistant Burkitt lymphoma cell line models
Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 - an analysis of gene expression in formalin-fixed paraffin-embedded tissue
Targeting the B-cell receptor (BCR) signaling pathway in Burkitt lymphoma (BL)
Rituximab and second generation monoclonal antibodies in B-NHL
PGDFR blockade as a novel therapy for NPMALK+ anaplastic large cell lymphoma
Reduced intensity allogeneic stem cell transplantation followed by targeted immunotherapy in patients with recurrent Hodgkin lymphoma: the lymphoma cell therapy consortium (LCTC) multicenter clinical trials
Safety and efficacy of intrathecal (IT) liposomal cytarabine (L-Ara-C) in children, adolescent and young adult (CAYA) patients with de-novo mature B-cell lymphoma/leukemia (MBLL)
Regulation of DLEU1 expression significantly alters survival in rituximab-treated DLEU1 knockout and overexpressed human Burkitt lymphoma (BL) xenograft NSG mouse model: DLEU1 may act as a tumor suppressor gene in BL
Incidence and risk factors of pediatric post-transplant lymphoproliferative disorder following allogenic hematopoietic stem cell transplantation: Japan Society for Hematopoietic Cell Transplantation (JSHCT) collaborative study
18F-FDG-PET/CT in the assessment of bone marrow involvement in pediatric Non-Hodgkin lymphoma
Lymphoma associated with a constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
Factors associated with time to diagnosis of childhood and adolescent non-hodgkin lymphoma in Peru
Follicular lymphoma in adolescents and young adults: the MD Anderson experience
Study of some related factors to treatment result in childhood Non Hodgkin's Lymphoma
Good outcome of patients with diffuse large Bcell lymphoma (DLBCL) and Burkitt lymphoma (BL) treated with the protocol AIEOP LNH-97
Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol
Response-adapted sequential immunochemotherapy of post-transplant lymphoproliferative disorders in pediatric solid organ transplant recipients: results from the prospective Ped-PTLD 2005 trial
Hematopoietic stem cell transplantation using reduced-intensity conditioning regimen for relapsed or refractory anaplastic large cell lymphoma: 11 cases of children, adolescents and young adults in Japan
Survival among Kenyan children treated for endemic Burkitt lymphoma between 2003 and 2011: a longitudinal analysis of risk factors
Therapeutic effects of ALT-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against pediatric Burkitt lymphoma (BL)
PD-L1 inhibits the activity of T-cell in extranodal natural killer (NK)/T-cell lymphoma, nasal type
Immunomodulatory effects of Vinblastine on human dendritic cell maturation and antigen-specific immune responses in vitro
Clinical, histopathologic and molecular features of mycosis fungoides in children and young adolescents
Targeting autophagy enhances the antitumoral action of Crizotinibin ALK-positive anaplastic large cell lymphoma
Combination of histone deacetylase and proteasome inhibitors induces enhanced killing of Epstein-Barr virus-positive lymphoblastoid cells through suppression of the function of EBNA-3c protein
Analysis of Ig/TCR gene rearrangements detection for diagnosis of children lymphoblastic lymphoma MRD
UCH-L1 synergizes with BCL6 and predicts a poor outcome in diffuse large B-cell lymphoma
GRK2 is a novel modulator of the MALT1 protease
Hematopoietic stem cell transplantation for childhood, adolescent and young adult NHL
Molecular genetics in Non-Hodgkin lymphoma for the clinician
Epidemiology of childhood and adolescent Non-Hodgkin lymphoma
Prevention and treatment of tumor lysis syndrome
Primary CNS lymphoma in children and adolescents
Presentation and treatment outcomes of children with Burkitt lymphoma at Uganda Cancer Institute
Incidence and outcomes of rare pediatric Non-Hodgkin lymphomas
Treatment outcome of Chinese children and adolescent with extranodal natural killer/T-cell lymphoma, nasal type
Anti-CD20 chimeric antigen receptor modified expanded natural killer cells have significant cytotoxicity against poor risk CD20+ Burkitt lymphoma in vitro and in xenografted NSG mice
Risk-adapted therapy for patients with relapsed or refractory ALCL - final report of the prospective ALCL-relapse trial of the EICNHL
Analysis of new pronostic molecular markers in French pediatric T-LBL treated according to the EuroLB02 trial.
Genetics of childhood and adolescent T-Lymphoblastic lymphoma
Diagnosis and treatment of childhood and adolescent B-Lymphoblastic lymphoma
Targeted therapy in childhood and adolescent T-Lymphoblastic lymphoma
Minimal disseminated disease in pediatric T-cell lymphoblastic lymphoma: impact on outcome
Adolescents and young adults with T-lymphoblastic lymphoma treated on a paediatric ALL-like protocol have improved outcomes that are predicted by early PET response
Increased expression of miR-223 is associated with worst prognosis in childhood T-cell lymphoblastic lymphoma
Case report of ‘adult’ follicular lymphoma with a fulminant transformation into an aggressive large B-cell lymphoma in 16 year-old child
Overexpression of DLEU1 gene significantly induces programmed cell death in primary mediastinal B-Cell lymphoma (PMBL): DLEU1 may be a tumor suppressor gene in PMBL
Clinical management of rare Non-Hodgkin lymphomas (R-NHLs) in children: the AIEOP experience
AYA with NHL have survival inferior to children and adults - a UK registry study
Characteristics and outcome of children and adolescents with constitutional conditions suffering from Non-Hodgkin's lymphoma
Two patients of avascular necrosis of the bone after an autologous bone marrow transplantation and multi-drug chemotherapy in adolescent and young adult generations with Non-Hodgkin lymphoma
Distinctive features of Non-Hodgkin's lymphoma (NHL) in Nijmegen breakage syndrome (NBS)
HDC and auto-SCT in adolescent and young adult patients with aggressive non-Hodgkin lymphoma: should adolescents be included in young adult group?
Expression of VEGF-A by neoplastic cells in T-cell lymphoblastic lymphoma: possible therapeutic implications related to immunomodulatory properties of this cytokine
Primary B-cell lymphoma of liver and spleen: report of two cases
An unusual site, breast involvement in an adolescent girl with Burkitt's lymphoma
The role of PET/CT versus bone marrow biopsy in the initial evaluation of bone marrow infiltration in pediatric Non-Hodgkin lymphoma
Clinical characteristics of 26 children with Burkitt's leukemia and outcome of treatment with revised LMB 89 protocol
A lymphomatous presentation of mixed lineage T/Myeloid leukemia
A case series of adolescent bone lymphoma
Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells
Second and subsequent relapses of ALCL: EICNHL experience
CNS progression during therapy for high-risk relapsed ALK-positive anaplastic large cell lymphoma in children and adolescents - a case series
Quality control of standardized methods for NPM-ALK RT-PCR and anti-ALK-Antibody-Measurement for anaplastic large cell lymphoma - a report of the EICNHL Reference Laboratory Group
Expression analysis of combination treatments in anaplastic large cell lymphoma
Primary cutaneous lymphomas of childhood in Japan
Hemophagocytic lymphohistiocytosis associated with anaplastic large cell lymphoma
Prognostic value of the detection of circulating tumor cells by RT-PCR in NPM-ALK-positive anaplastic large cell lymphoma
Vinblastine as salvage treatment for relapsed anaplastic large-cell lymphoma: 4 cases report
Pediatric primary mediastinal large B-cell lymphoma in Japan
The treatment of mature B-NHL with the involvement of CNS in children and adolescents with chemotherapy and rituximab; experience of multicentral study
Follicular lymphoma of children in Japan
Outcomes of Burkitt lymphoma in children from a single paediatric cancer center in Singapore
Disruption of IRF4 in pediatric diffuse large B-cell lymphoma
Pediatric nodal marginal zone lymphoma in a Japanese boy
Primary mediastinal large B-cell lymphomas: results of the protocol AIEOP LNH97 ad interim
Genome-wide analysis of follicular lymphoma pediatric type
Comparison of treatment outcome of NHL-BFM-90/95 and CHOP/R-CHOP regimen for children and adolescents with diffuse large B cell lymphoma
Outcome of relapsed mature B-cell lymphoma and leukemia: the AIEOP experience
Direct digital profiling of multiplexed mRNA expression from degraded formalin fixed paraffin embedded aggressive paediatric B-cell lymphoma tumour tissue
High-resolution copy number analysis using low input, degraded DNA from fine-needle aspirates and macrodissected archival Burkitt lymphoma material
Pediatric Burkitt lymphomas (BL) differ from adult BL by less frequent ID3 mutations
The clinical features and outcome of 16 Burkitt's lymphoma cases with testicular involvement without radiation therapy: a single center study from Beijing
Chemotherapy reduction for early responders patients with advanced stages Burkitt lymphoma
Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study Group B-NHL03 study
Genetic profile of two pediatric aggressive lymphoma cases with relapse
Pediatric diffuse large B-cell lymphoma in Japan
Review of a tertiary hospital's lymphomas over the past 10 years
Non Hodgkin diffuse large cell lymphoma as a second malignancy in a child with chronic myeloid leukemia (CML)
Non-Hodgkin lymphoma associated with immunodeficiency at the National Institute of Pediatrics
Late effects of Rituximab in combination with chemotherapy in patients with B-cell NHL or BAL
Pediatric patients with marginal zone lymphoma - BFM experience
Clinical treatment and outcome of 189 mature B-cell Non-Hodgkin lymphoma from a single center in China
Clinical features in childhood Non-Hodgkin lymphoma with central nervous system involvement
Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: genome-wide analysis and clinical outcome under treatment in a prospective clinical trial for lymphoblastic lymphoma
Six cases of precursor B lymphoblastic lymphoma induced by calvarial masses in children and literature review
Persistent positive uptake of 18F-FDG during treatment of B-LL (B lymphoblastic lymphoma) in a 5-year-old Algerian child
Precursor B-cell lymphoblastic lymphoma in children: Hacettepe experience
Role of bone marrow immunohistochemistry in diagnosis and staging of childhood lymphoblastic/lymphoproliferative malignancies: single center report
The comparison of different central nervous system prophylaxis strategies among children with lymphoblastic lymphoma
Obinutuzumab (GA101) significantly inhibits cell proliferation in primary mediastinal B-cell lymphoma (PMBL): Obinutuzumab may be a future targeted agent in the treatment of PMBL
Ibrutinib alone and in combination with dexamethasone significantly inhibits cell proliferation in primary mediastinal B-Cell Lymphoma (PMBL): Ibrutinib may be a potential targeted agent in combination therapy in patients with PMBL
Allogeneic stem cell transplantation with reduced intensity conditioning: a therapeutic option for X-linked lymphoproliferative disorder complicated by Burkitt lymphoma
Relevance between PD-L1 and EBER expression in lymphoma
Non-Hodgkin lymphoma after solid organ transplantation in children; data from one centre
Epidemiology and outcome of post-transplant lymphoproliferative disorder in pediatric liver transplant recipients
Detection of NPM-ALK-reactive T-cell responses with long overlapping peptides in NPM-ALK+ anaplastic large cell lymphoma (ALCL) patients
Hodgkin's Disease/Hodgkin-PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules
NPM-ALK epitopes recognized by anti-ALKantibodies in ALCL patients
Incorporating mitochondrial DNA (MtDNA) measurement to supplement minimal residual disease assessment in B-NHL/Leukemia treatment strategies
DLEU1 significantly alters programmed cell death in chemoimmunotherapy treated TALENs-induced DLEU1 Burkitt lymphoma (BL) knockout: DLEU1 may act as a tumor suppressor gene in BL
Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL
Obinutuzumab versus rituximab significantly enhances apoptosis, ADCC in vitro and overall survival in vivo of rituximab sensitive/resistant Burkitt lymphoma (BL)
Understanding chaperone-mediated NPM-ALK folding: principles of substrate recognition and consequences on kinase activity
MYC expression in pediatric and adult post-transplant lymphoproliferative disorders
XPO1-ALK fusion gene: a new variant ALK partner gene with an uncommon ALK fusion site in ALCL
Patient-derived xenograft and in vivo bioluminescent modelling of B-cell NHL
UCH-L1 and its catalytic activity are required to promote spontaneous and myc-induced B-cell lymphoma
Clinical spectrum of lymphoma in children and adolescents in Central Malawi
Kaposi sarcoma inflammatory cytokine syndrome (KICS) in HIV-infected children in Malawi, a distinct clinical presentation characterized by interleukin-6 related viral pathophysiology
A multicenter study of the Groupe Franco Africain d'Oncologie Pédiatrique for the treatment of children with Burkitt lymphoma in sub-Saharan countries
Clinical characteristics, complications and survival in patients diagnosed with large B-cell lymphoma at the National Institute of Pediatrics
Primary central nervous system Non-Hodgkin lymphoma in immunocompetent children: experience at National Institute of Pediatrics in Mexico
Neurologic complications of Non-Hodgkin lymphoma in children
Burkitt lymphoma - evaluation of 40 patients in a low-income area
Rituximab treatment in B-cell NHL children in two Brazilian institutions
Survival among CHOP-treated children with endemic Burkitt lymphoma (eBL) in Malawi
Rare mediastinal gray-zone lymphoma
Should allogenic hematopoetic stem cell transplantation a treatment be an option for patients with Nijmegen breakage syndrome and lymphoid malignancy?
Therapeutic effects of Romidepsin, a histone deacetylase inhibitor, in combination with anti-C20 chimeric antigen receptor modified expanded natural killer cells against pediatric Burkitt lymphoma (BL)
Obinutuzumab versus Rituximab significantly enhances apoptosis and ADCC in vitro and overall survival in vivo of rituximab sensitive/resistant Burkitt Lymphoma (BL)
Prolonged Ibrutinib treatment of Burkitt lymphoma cells leads to Ibrutinib resistance via changes in BTK and PLCγ2 signalling
Gemcitabine in relapsed panniculitis-like T-cell lymphoma
Ruxolitinib significantly prolonged survival in both a primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) xenograft NSG mouse model: Ruxolitinib may be a potential adjuvant agent in the treatment of PMBL and HL
Tumor lysis syndrome: effective management with low doses rasburicase
Changes in CD19 localization after CD19-directed chimeric antigen receptor T cell therapy for primary mediastinal large B cell lymphoma
Blast plasmacytoid dendritic-cell tumor with skin and bone marrow involvement in a child
Excellent outcome in pediatric patient with advance stage extranodal NK/T cell lymphoma, nasal type
High PD-L1 expression is a novel prognostic indicator in extranodal natural killer (NK)/T-cell lymphoma, nasal type
Prognosis of rare NHL in children - observations on PTCL of Polish Pediatric Leukemia/Lymphoma Study Group
Mycosis fungoides in children - description of two cases
Recurrent activating MAPK pathway gene mutations in Langerhans cell histiocytosis
Burkitt lymphoma at a public pediatric referral cancer center in Western Kenya